You are here: Industry Insights > prescription drugs

News List

US drug prices rose three times faster than inflation since 2007 europeanpharmaceuticalreview
March 05, 2020
A study of over 602 brand-name prescription drugs shows that list prices increased over 1.5 times and net prices rose over 3.5 times inflation in the past decade.
Novartis clear to focus on prescription drugs with completion of Alcon spin-off firstwordpharma
April 09, 2019
Novartis announced Tuesday that it completed the spin-off of its Alcon eye care devices business into a standalone ……
GSK’s chairman Sir Philip Hampton steps down pharmaphorum
January 22, 2019
GlaxoSmithKline is searching for a new chairman after Sir Philip Hampton announced he is to step down in the wake of the company’s split into two businesses.
Perrigo plans to separate prescription drugs business pharmatimes
August 10, 2018
Perrigo’s Board of Directors has approved a plan to separate the company's Prescription Pharmaceuticals (Rx) business, following a strategic portfolio review.
Reference pricing encourages patients to choose cheaper prescription drugs worldpharmanews
August 23, 2017
As prescription drug spending continues to rise in the United States, along with prices for new and well-established drugs,
Top 10 Prescription Drugs by Ad Expenditure in 2016 en-cphi.cn
August 04, 2017
Budgets of pharmaceutical companies for DTC ads are increasing year by year: the number of brands spending at least USD 50 million annually, as well as the number of brands spending over USD 100 million, have both more than doubled since 2012.
Sales of Boehringer Ingelheim's prescription drugs jump 12 percent in first half firstwordpharma
August 03, 2017
Boehringer Ingelheim said Wednesday that sales of prescription medicines climbed 12 percent in the first half of the year to 6.1 billion euros ($7.2 billion), boosted by the company's diabetes portfolio and the of idiopathic pulmonary fibrosis treatment O
Cancer survivors skip prescription drugs due to cost: Study firstwordpharma
February 21, 2017
According to research findings published in the journal Cancer, many cancer survivors are requesting lower cost medications or skipping doses altogether due to the high cost of the drugs, as reported in Breitbart.
Johnson & Johnson's Q4 sales boosted by new drugs; annual guidance comes in below estimates firstwordpharma
January 25, 2017
Johnson & Johnson announced Tuesday that fourth-quarter sales of prescription drugs rose 2.1 percent year-over-year to $8.2 billion, with growth driven by revenue from new products including Imbruvica, Darzalex and Xarelto.
J&J to reveal drug price increases next month pharmafile
January 17, 2017
Next month, Johnson & Johnson will reveal the average price increases of its prescription drugs in a move to increase its transparency with patients; the information due to be released by the company will include the list price and net price.